Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer

Clinical trial NCT00079326 · TERMINATED

Trial details

NCT number: NCT00079326
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2004-01-01
Primary completion: 2008-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.